Skip to content

Use of herbal medication for oral submucous fibrosis

Comparative Evaluation Of Variations In Clinical Signs And Symptoms In Oral Submucous Fibrosis (OSMF) Patients With The Use Of Polyherbal Medication Therapeutic Ultrasound And Combination Of Polyherbal Medication And Therapeutic Ultrasound

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055839
Enrollment
45
Registered
2023-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K135- Oral submucous fibrosis

Interventions

None listed

Sponsors

Sharad pawar dental college and hospital Datta Meghe Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above the age of 18 years clinically diagnosed as oral submucous fibrosis.

Exclusion criteria

Exclusion criteria: 1. Subjects having known allergic reaction to turmeric, black pepper, cinnamon. 2. Subjects on any other treatment modalities for oral sub mucous fibrosis for last 6 months. 3. Subjects with past history of and/or on medication for any systemic and metabolic disorders, psychiatric or dermatologic diseases. 4. Pregnant or lactating mothers.

Design outcomes

Primary

MeasureTime frame
Relief from the signs and symptoms of oral submucous fibrosis . -Reduction in burning sensation -Improvement on cheek flexibility -Improvement in tongue protrusion -Increases in mouth opening Timepoint: Baseline 4 weekly 8 weekly 12 weekly 16 weekly 20 weekly 24 weekly

Secondary

MeasureTime frame
Reduction in malignant potentialTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Mrunal Meshram

Sharad pawar dental college and hospital, Datta Meghe Institute of Medical Sciences

vidyalohekadu@gmail.com9960445040

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026